Protalix BioTherapeutics Inc.

ASE:PLX

1.54

+0.04 (+2.67%)

4:32:05 PM EDT: $1.54 0.00 (0.00%)

Market Cap (Intraday)	125.87M
Current PE	32.21
Forward PE	11
2yr Forward PE	3.42

See more stats

Estimates Current Quarter

Revenue	$15.53 Million
Adjusted EPS	$0.04

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Protalix BioTherapeutics Inc. Stock, ASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601

United States of America

Phone: +1.201.696.9345

Number of Employees: 213

http://www.protalix.com

Description

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.